Literature DB >> 18407145

Pheochromocytoma: 1926-1993.

W F Young1.   

Abstract

Pheochromocytoma is a tumor frequently sought and rarely found. It is associated with spectacular cardiovascular disturbances and, when correctly diagnosed and properly treated, it is curable; when undiagnosed or improperly treated, it can be fatal. Catecholamine-producing tumors that arise from chromaffin cells of the adrenal medulla and sympathetic ganglia are termed pheochromocytomas and paragangliomas, respectively. However, the term pheochromocytoma has become the generic name for all catecholamine-producing tumors. The biochemical diagnosis is straightforward. The localization of pheochromocytoma has been greatly facilitated by advances in computerized imaging and meta-iodobenzylguanidine scanning. Treatment with preoperative alpha- and beta-adrenergic blockade followed by surgical excision of the pheochromocytoma are associated with very low morbidity and mortality.

Entities:  

Year:  1993        PMID: 18407145     DOI: 10.1016/1043-2760(93)90035-d

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  9 in total

Review 1.  Autonomic nervous system and cancer.

Authors:  Marta Simó; Xavier Navarro; Victor J Yuste; Jordi Bruna
Journal:  Clin Auton Res       Date:  2018-03-28       Impact factor: 4.435

2.  Intrahepatic cholestasis as a paraneoplastic syndrome associated with pheochromocytoma.

Authors:  C H Chung; C H Wang; C Y Tzen; C P Liu
Journal:  J Endocrinol Invest       Date:  2005-02       Impact factor: 4.256

3.  Are patients with hormonally functional phaeochromocytoma and paraganglioma initially receiving a proper adrenoceptor blockade? A retrospective cohort study.

Authors:  Henrique Vara Luiz; Mary Jane Tanchee; Maria G Pavlatou; Run Yu; Joan Nambuba; Katherine Wolf; Tamara Prodanov; Robert Wesley; Karen Adams; Tito Fojo; Karel Pacak
Journal:  Clin Endocrinol (Oxf)       Date:  2016-04-15       Impact factor: 3.478

Review 4.  Adrenal causes of hypertension: pheochromocytoma and primary aldosteronism.

Authors:  William F Young
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 5.  Recent advances in the management of pheochromocytoma and paraganglioma.

Authors:  Akiyo Tanabe; Mitsuhide Naruse
Journal:  Hypertens Res       Date:  2020-08-11       Impact factor: 3.872

6.  A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma.

Authors:  Anna M Sawka; Ally PH Prebtani; Lehana Thabane; Amiram Gafni; Mitchell Levine; William F Young
Journal:  BMC Endocr Disord       Date:  2004-06-29       Impact factor: 2.763

7.  Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?

Authors:  Anna M Sawka; Lehana Thabane; Amiram Gafni; Mitchell Levine; William F Young
Journal:  BMC Endocr Disord       Date:  2005-02-28       Impact factor: 2.763

Review 8.  An ectopic renin-secreting adrenal corticoadenoma in a child with malignant hypertension.

Authors:  Abraham M Kaslow; Anne Riquier-Brison; Janos Peti-Peterdi; Nick Shillingford; Josephine HaDuong; Rajkumar Venkatramani; Christopher P Gayer
Journal:  Physiol Rep       Date:  2016-03

9.  Evaluating the optimum rest period prior to blood collection for fractionated plasma free metanephrines analysis.

Authors:  T P Griffin; R Casey; D Wall; M Bell; P M O'Shea
Journal:  Pract Lab Med       Date:  2016-05-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.